The Cholangiocarcinoma Research Institute, led by Assoc. Prof. Dr. Watcharin Loylom, Acting Director of the Cholangiocarcinoma Research Institute, Khon Kaen University, and the Cholangiocarcinoma Foundation, in collaboration with the Kalasin Provincial Administrative Organization, the Kalasin Provincial Public Health Office, Phudin Subdistrict Municipality, and Laoluang Subdistrict Health Promotion Hospital, organized the "Liver Fluke and Cholangiocarcinoma Eradication Campaign" from June 25-27, 2025, at the Phudin Subdistrict Municipality Office and Laoluang Subdistrict Health Promotion Hospital, Mueang District, Kalasin Province.
On June 27, 2025, the opening ceremony of the activity was held, presided over by Mr. Prayong Mokpha, Deputy Mayor of Kalasin Provincial Administrative Organization. Mr. Sarawut Samranmol, Mayor of Phudin Subdistrict Municipality, Mueang Kalasin District, Kalasin Province, presented the report on the event. Assoc. Prof. Dr. Watcharin Loylom, Acting Director of the Cholangiocarcinoma Research Institute, Khon Kaen University, spoke about the background of the screening unit project, and Dr. Taweerat Srikulwong, Provincial Public Health Officer of Kalasin, discussed the participation in eliminating liver fluke disease and cholangiocarcinoma according to the national strategic plan. The event concluded with a lecture on "Understanding Liver Fluke Disease and Preventing Cholangiocarcinoma" by Prof. Dr. Paiboon Sitthithavorn, Advisor to the Cholangiocarcinoma Research Institute, Khon Kaen University. Following the lecture, the executive committee visited the liver fluke and cholangiocarcinoma screening unit.
Activities held from June 25-27, 2025, attracted participants from local government agencies, residents of Phudin Subdistrict, and surrounding areas. Participants underwent urine tests for liver fluke infection and bile duct cancer screening using ultrasound. A total of 1,249 people underwent urine tests, with 307 (24.58%) testing positive for liver fluke infection. 929 people underwent ultrasound examinations. Of those at risk, 32 (3.44%) were referred for suspected bile duct cancer (CCA), and 20 (2.15%) were referred for other reasons.